The delay, narrowed approval, and extra study steps raise concerns about the status of and potential added requirements for other COVID vaccines.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
In the US, a new study on Pfizer vaccine effectiveness in kids shows solid 2-dose COVID-19 protection.
The Centers for Disease Control and Prevention (CDC) said COVID-19 vaccine uptake among children 5 to 11 years old in the United States remained low during the first 11 weeks of vaccine eligibility, especially in high social vulnerability index (SVI) areas. The research was published today in Morbidity and Mortality Weekly Report (MMWR).
Protection against hospital illness was 85% for 2 doses against Alpha and Delta and 86% for 3 doses against Omicron.
In the US, lawmakers scramble to find funding for COVID-19 activities.
While Medicare beneficiary hospitalizations for non–COVID-19 diagnoses fell sharply in March and April 2020 and stayed low through September 2021, death rates after hospitalization rose substantially—particularly for Black and Hispanic patients, finds a study yesterday in JAMA Network Open.
"These findings imply that the pandemic may substantially contribute to the world dementia burden."
The United States continues to report the most COVID-19 fatalities of any country.
Continuing the corticosteroid dexamethasone after hospital release didn't benefit COVID-19 patients who didn't complete the 10-day drug regimen during their stay, finds a study published yesterday in JAMA Network Open.
The imaging differences between COVID-19 and non-COVID patients were modest, about 2%.
Different approaches may be needed in the future, experts say, such as vaccines that target a specific variant.
